Series A - Eiger BioPharmaceuticals - Apr 15, 2011 Funding Round Profile - Cointime

Bitcoin $95,117.54 -1.49%
Ethereum $3,448.33 +3.61%
BNB $642.62 -1.91%
Optimism $2.32 +6.56%
Arbitrum $0.91 +9.63%
Solana $240.01 -4.03%
Polygon $0.57 +4.00%
Cosmos $8.02 -4.31%
Avalanche $41.61 +3.30%

Bitcoin $95,117.54 -1.49%
Ethereum $3,448.33 +3.61%
BNB $642.62 -1.91%
Optimism $2.32 +6.56%
Arbitrum $0.91 +9.63%
Solana $240.01 -4.03%
Polygon $0.57 +4.00%
Cosmos $8.02 -4.31%
Avalanche $41.61 +3.30%

Eiger BioPharmaceuticals

company

Funding Round

Series A

Money Raised

$ 14.46M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
InterWest Partners	-	-	-	Detail
Vivo Capital	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Feb 25, 2009	Series A	$ 8.30M	InterWest Partners,Vivo Capital	Detail
Jan 1, 2007	Seed	0	RA Capital Management	Detail